The Texas Heart Institute

 

The Texas Heart Institute is an independent, nonprofit organization that is improving cardiovascular health through trailblazing research, thought leadership, education, and patient care. Our vision is to bring the future of cardiovascular care to life. Today THI is led by Dr. Joseph Rogers, an internationally recognized cardiologist and highly published ...
read more ↘

 

The Texas Heart Institute
M

Updates on the CABANA and AMAZE Trials: What Is the Efficacy of Catheter Ablation vs. Antiarrhythmic Drug Therapy Among Patients With Atrial Fibrillation? Does the Left Atrial Appendage Occluder Help in the Management of Permanent A-Fib?

By The Texas Heart Institute FEATURING Mehdi Razavi
By The Texas Heart Institute FEATURING Mehdi Razavi
935 views
April 20, 2021
0 Comments
Login to view comments. Click here to Login
2020
06:32
The Texas Heart Institute

Menopause vs. Manopause: Why Have the CVD Rates of Death Been on the…

Feat. S. Coulter
17:47
The Texas Heart Institute

Women and Heart Disease: A Look at Hormone Trials for Post-Menopausa…

Feat. S. Coulter
08:15
The Texas Heart Institute

Female Patients and Heart Disease: Does the Timing Of Hormone Therap…

Feat. S. Coulter
10:13
The Texas Heart Institute

Manopause: Is It a Manufactured Disease to Get Men to Take Testoster…

Feat. S. Coulter
05:50
The Texas Heart Institute

Male Menopause: Does Testosterone Therapy Increase Cardiovascular Ri…

Feat. S. Coulter
16:57
The Texas Heart Institute

Status of Women Cardiovascular Surgeons in the US Today

Feat. O. Preventza
26:32
The Texas Heart Institute

TAVR vs. SAVR: What Can Be Learned from Recent Prohibitive, Intermed…

Feat. Z. Krajcer
11:20
The Texas Heart Institute

Venous Arterialisation for CLTI: How Does Decreased Renal Function L…

Feat. M. Montero-Baker
15:05
The Texas Heart Institute

Venous Arterialisation as Treatment for CLTI: What Are the Two Diffe…

Feat. M. Montero-Baker
11:28
The Texas Heart Institute

Cryptogenic Stroke: Is PFO Implicated?

Feat. R. David Fish
14:53
The Texas Heart Institute

Cryptogenic Stroke: When Do We Close A PFO?

Feat. R. David Fish
10:00
The Texas Heart Institute

Cardio-Oncology: Who Are the Cancer Patients at Risk For Developing …

Feat. J. Carlos Plana
17:49
The Texas Heart Institute

Cardiology Considerations in Cancer Patients: How Is Injury Detected…

Feat. J. Carlos Plana
07:51
The Texas Heart Institute

What's New in Atrial Fibrillation

Feat. M. Razavi
08:30
The Texas Heart Institute

Updates on the CABANA and AMAZE Trials: What Is the Efficacy of Cath…

Feat. M. Razavi
23:21
The Texas Heart Institute

Diabetes Management for the Cardiac Patient: How to Utilize Latest G…

Feat. D. Aguilar
17:37
The Texas Heart Institute

CAD Assessment: What Are the Risk Formulas? What Are the Associated …

Feat. E. Hernandez
15:07
The Texas Heart Institute

Coronary Artery Disease and the Use of Aspirin: What Is the Efficacy…

Feat. E. Hernandez
12:40
The Texas Heart Institute

Triglyceride Reduction for CV Risk: What Do We Know About the Associ…

Feat. S. Virani
06:18
The Texas Heart Institute

Insights into Triglyceride Reduction: What Do the Treatment Guidelin…

Feat. S. Virani
11:55
The Texas Heart Institute

Triglyceride Lowering Therapies: What Have We Recently Learned? What…

Feat. S. Virani
07:09
The Texas Heart Institute

Heart Failure in Women: What Is the Epidemiology?

Feat. J. D. Estep
14:25
The Texas Heart Institute

Women and Heart Failure: What Does the Evidence Show for Differences…

Feat. J. D. Estep
18:29
The Texas Heart Institute

Heart Failure and Women: What Are the Devices and Sex Specific Medic…

Feat. J. D. Estep
52:49
The Texas Heart Institute

The Latest Advances in TAVR: How to Significantly Reduce Conduction …

Feat. Z. Krajcer, H. Gada
36:33
The Texas Heart Institute

Current Status of TAVR: How Has Site Preference Affected Outcomes? W…

Feat. Z. Krajcer, V. Thourani